Epstein-Barr virus (EBV) is a herpesvirus which is associated with several malignancies. A central aspect of the life cycle and pathogenesis of EBV is a latent state of infection in which the viral chromosome is maintained as an episome. A single EBV- encoded protein, EBNA-1, allows the EBV chromosome to be maintained by binding to oriP, where it directs DNA replication to initiate and where it also acts to prevent the EBV chromosome from being lost from mitotically active cells. The replication function of oriP appears to be essential for the infection of primary B cells, although it is not needed when EBV infects established cell lines in culture. Molecular and genetic studies are proposed to investigate how EBNA-1 and cellular factors direct replication to initiate at oriP.
Four specific aims are described: (1) We have evidence that in order to support replication initiation, two dimers of EBNA-1 must form a precise structure at oriP that involves a large DNA bend. We will investigate the angle of bending and whether a specific geometry is required. (2) We will take advantage of a wealth of information about DNA replication that has emerged from studies of yeast and Xenopus to begin to investigate the human proteins that may control initiation of DNA replication at oriP, using chromatin immunopreciptation and in vivo footprinting assays. (3) We will isolate replication-defective mutants of EBNA-1 that retain all other EBNA-1 activities and, therefore, may fail to perform an initiation step, such as interact with a host factor. (4) We will determine precisely where replication initiates at oriP by mapping the 5' ends of leading nascent strands. Each of these independent and complementary approaches should provide key insight into how replication initiates at oriP. The studies will also to be relevant to our understanding the replication of human chromosomes.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA043122-13A1
Application #
6200599
Study Section
Experimental Virology Study Section (EVR)
Program Officer
Daschner, Phillip J
Project Start
1986-07-01
Project End
2005-05-31
Budget Start
2000-06-15
Budget End
2001-05-31
Support Year
13
Fiscal Year
2000
Total Cost
$274,356
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Hodin, Theresa L; Najrana, Tanbir; Yates, John L (2013) Efficient replication of Epstein-Barr virus-derived plasmids requires tethering by EBNA1 to host chromosomes. J Virol 87:13020-8
Paulson, Emily J; Fingeroth, Joyce D; Yates, John L et al. (2002) Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells. Virology 299:109-21
Bashaw, J M; Yates, J L (2001) Replication from oriP of Epstein-Barr virus requires exact spacing of two bound dimers of EBNA1 which bend DNA. J Virol 75:10603-11
Dhar, S K; Yoshida, K; Machida, Y et al. (2001) Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin. Cell 106:287-96
Yates, J L; Camiolo, S M; Bashaw, J M (2000) The minimal replicator of Epstein-Barr virus oriP. J Virol 74:4512-22
Norio, P; Schildkraut, C L; Yates, J L (2000) Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines. J Virol 74:8563-74
Lee, M A; Diamond, M E; Yates, J L (1999) Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus. J Virol 73:2974-82
Fingeroth, J D; Diamond, M E; Sage, D R et al. (1999) CD21-Dependent infection of an epithelial cell line, 293, by Epstein-Barr virus. J Virol 73:2115-25
Yates, J L; Camiolo, S M; Ali, S et al. (1996) Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function. Virology 222:1-13
Hsieh, D J; Camiolo, S M; Yates, J L (1993) Constitutive binding of EBNA1 protein to the Epstein-Barr virus replication origin, oriP, with distortion of DNA structure during latent infection. EMBO J 12:4933-44

Showing the most recent 10 out of 14 publications